The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Aksheit Kakani
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
BSE has received a disclosure under Regulation 29(2) of the SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011, filed by Aksheit Kakani in relation to shares of Godavari Drugs Ltd. This regulation requires promoters, persons acting in concert, or shareholders holding 5% or more to report changes in their shareholding. The actual transaction details (buy/sell, quantity, price, resulting shareholding percentage) are not visible in the source document, as the BSE page returned an error and only the headline was available.
Without the actual transaction data, the market impact cannot be determined. Investors should check the full disclosure on BSE/NSE to see if this is a buy, sell, or encumbrance change, and assess whether it signals promoter confidence, profit booking, or a creeping acquisition towards a takeover threshold.